SYED JAFFERY: Open Payments
NPI 1427184829 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 62 payments from 12 companies in 2025. Trend: 2023 $199 · 2024 $523 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $339 |
| Alkermes, Inc. | 11 | $257 |
| E.R. Squibb & Sons, L.L.C. | 11 | $192 |
| Axsome Therapeutics, Inc. | 4 | $120 |
| ABBVIE INC. | 3 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Lundbeck LLC | 2 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
Products named: ARISTADA, HETLIOZ, COBENFY, Auvelity, FANAPT, VRAYLAR, INVEGA SUSTENNA, REXULTI.
Industry payments across NY — which companies pay providers there.
